Daniel N Swisher Jr Corcept Therapeutics Inc (CORT) insider trading activity

Daniel N Swisher Jr is of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 0 shares of CORT, which is worth approximately $0. The most recent transaction as insider was on Sep 01, 2023, when has been sold 1,550 shares (Common Stock) at a price of $6.55 per share, resulting in proceeds of $10,152. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Daniel N Swisher Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 01 2023	BUY Exercise of conversion of derivative security	$10,152 $6.55 p/Share	1,550 Added 50.0%	1,550 Common Stock
Aug 07 2023	SELL Open market or private sale	$85,927 $30.15 p/Share	2,850 Reduced 100.0%	0 Common Stock
Aug 07 2023	BUY Exercise of conversion of derivative security	$17,698 $6.21 p/Share	2,850 Added 50.0%	2,850 Common Stock
Aug 08 2022	SELL Payment of exercise price or tax liability	$131,020 $28.39 p/Share	4,615 Reduced 23.08%	15,385 Common Stock
Aug 08 2022	SELL Open market or private sale	$435,703 $28.32 p/Share	15,385 Reduced 100.0%	0 Common Stock
Aug 08 2022	BUY Exercise of conversion of derivative security	$131,000 $6.55 p/Share	20,000 Added 50.0%	20,000 Common Stock
Sep 02 2021	SELL Open market or private sale	$162,750 $21.7 p/Share	7,500 Reduced 100.0%	0 Common Stock
Sep 02 2021	BUY Exercise of conversion of derivative security	$49,125 $6.55 p/Share	7,500 Added 50.0%	7,500 Common Stock
Jun 02 2021	SELL Open market or private sale	$161,100 $21.48 p/Share	7,500 Reduced 100.0%	0 Common Stock
Jun 02 2021	BUY Exercise of conversion of derivative security	$49,125 $6.55 p/Share	7,500 Added 50.0%	7,500 Common Stock
Apr 05 2021	SELL Open market or private sale	$181,050 $24.14 p/Share	7,500 Reduced 100.0%	0 Common Stock
Apr 05 2021	BUY Exercise of conversion of derivative security	$49,125 $6.55 p/Share	7,500 Added 50.0%	7,500 Common Stock
Jan 19 2021	SELL Open market or private sale	$143,700 $28.74 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jan 19 2021	BUY Exercise of conversion of derivative security	$32,750 $6.55 p/Share	5,000 Added 50.0%	5,000 Common Stock
Oct 19 2020	SELL Open market or private sale	$88,300 $17.66 p/Share	5,000 Reduced 100.0%	0 Common Stock
Oct 19 2020	BUY Exercise of conversion of derivative security	$32,750 $6.55 p/Share	5,000 Added 50.0%	5,000 Common Stock

Also insider at

CERS

CERUS CORP Healthcare

Director

JAZZ

Jazz Pharmaceuticals plc Healthcare

President and COO

PTGX

Protagonist Therapeutics, Inc Healthcare

Director

DNS